Patients

1

2

3

4

Group

Mono Dual therapy

Mono Dual therapy

HAART

Mono Dual therapy

Sex

M

F

F

F

Year of birth

1996

1997

1998

2005

Maternal age (years)

31.8

34.9

39

33.4

Maternal CD4 T-cells count (/ml)

98

64

3%*

540

Maternal viral load (c/ml) [log10]

Unknown

340.000

[5.53]

880.000

[5.94]

400

[2.6]

Maternal treatment

AZT

AZT+3TC

AZT+3TC+NFV

AZT+3TC

Maternal mode of contamination

IVDU

Sexual

Sexual

Sexual

Mode of delivery

Vaginal

Vaginal

Elective caesarean

Elective caesarean

Co-infection

HCV

No

No

No

Children prophylaxis

AZT

AZT+3TC

AZT+3TC

AZT

Birth term (weeks)

42.9

40.1

39

38

Birth weight (g)

3,300

3,700

1,900

3,270


*: no absolute count available
IVDU : intravenous drug user, AZT : azidothymidine, 3TC : lamivudine, NFV : nelfinavir
Table 7: Four infected children’s characteristics.
Goto home»